secwatch.observer — SEC 8-K summary
======================================

Issuer:     EKSO BIONICS HOLDINGS, INC. (CHRN)
CIK:        0001549084
Form:       8-K
Filed at:   2023-10-26T23:59:59+00:00
Accession:  0001437749-23-029094
Event type: earnings
Sentiment:  positive
Materiality: 0.60
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Ekso Bionics Q3 revenue up 38% to $4.6M; net loss narrows to $0.24/share
------------------------------------------------------------------------

- Revenue of $4.6M, up 38% YoY; gross margin improved to 53% from 51%.
- Net loss narrowed to $3.4M ($0.24 per share) from $4.3M ($0.33) in Q3 2022.
- Sold 41 EksoHealth devices, including a record quarter of EVO unit sales.
- Cash on hand $9.9M at Sep 30, 2023, down from $20.5M at Dec 31, 2022.
- Company applied for CMS code determination for Indego Personal exoskeleton.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1549084/000143774923029094/0001437749-23-029094-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1549084/000143774923029094/ekso20231024c_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-23-029094

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer